Comparative Efficacy of Interleukin Inhibitors and JAK Inhibitors in Moderate to Severe Plaque Psoriasis.

Bimzelx (bimekizumab-bkzx) - UCB

Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim

Sotyktu (deucravacitinib) - BMS

http://www.ncbi.nlm.nih.gov/pubmed/42719781

Alexandra Daily; Brittany Shectman; Kiarra Krulikowski; London Danchulis; Suzanne I Riskin

Sep 11, 2026